ORMP Q2'26 Earnings: EPS estimate is 0.43 USD
Czytanie zajmuje mniej niż 1 minutę
ORMP (Oramed Pharmaceuticals Inc.) is set to announce its Q2'26 results on August 12, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at 0.43 USD. Learn more details at ORMP Financials page.
Revenue & EPS values are provided in USD
| Q2'25 | Q3'25 | Q4'25 | Q1'26 | Q2'26 | |
|---|---|---|---|---|---|
| Revenue Reported | — | — | — | — | — |
| Revenue Estimate | — | — | — | — | — |
| Revenue Surprise | |||||
| EPS Reported | 0.00 | 0.91 | |||
| EPS Estimate | (0.04) | (0.04) | (0.08) | 0.43 | |
| EPS Surprise | +100.00% |
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.